This session will explore the growing trend of large pharmaceutical and biotechnology companies making strategic investments in biotech start-ups and will look at the motivations on both sides of these transactions, what benefit each party expects to receive, strategies for securing and structuring strategic investments and the success rate of such investments. With a panel selected from both large pharma/biotech and start-up companies, we will look at this topic from the investors' and issuers' perspective.



Objectives:

Learn ways in which an early-stage biotechnology company can attract strategic investments.

Learn how to structure strategic investments to meet the needs of a strategic investor, and how these needs differ from venture capital investors.

Learn what effects taking strategic investments can have on existing and potential future collaboration partners and other strategic decisions.